LIFESAVER
Living Impact on Fetal Evolution: Shelter-Analyze-Validate-Empower Regulations
The preterm birth rate is increasing: in Europe, about 75 % of all neonatal deaths and 60 % of all infant deaths occur in infants born preterm. Based on the vision that every pregnant woman must live in a better and safer environment, the EU-funded LIFESAVER project will create a new digitally cloned in vitro system for emulation of prenatal conditions for drugs and pollutants transport at the uterine/placental interface. The system relies on the hybridisation of innovative technologies, integrating in silico/in vitro systems to enable screening for chemicals and pharmaceuticals that could affect the health of pregnant women, and at the same time reducing animal, pre-clinical and clinical testing needs
Total Eligible Budget
6,136,512.00 €
INL Eligible Budget
397,750.00 €
Total Funding
6,136,512.00 €
INL Funding
397,750.00 €
Start Date
01-11-2021
End Date
31-10-2025
Type of action
RIA Research and Innovation action
Grant Agreement Id
101036702
Programme
H2020-LC-GD-2020 Building a low-carbon, climate resilient future: Research and innovation in support of the European Green Deal
Funding Framework
HORIZON 2020
INL Role
Partner
Approval Date
27-05-2021
Main Objective